IP Verse

Alexion Pharmaceuticals vs. Amgen Technology Ireland Unlimited - UPC_CFI_124/2024

The case UPC_CFI_124/2024 was filed by the plaintiff Alexion Pharmaceuticals against the defendant Amgen Technology Ireland Unlimited on 19 Mar, 2024. The case decision was made on Jun 26, 2024.

Case Timeline

19 Mar, 2024
Case Filed
24 May, 2024
Written Procedure
14 Jun, 2024
Rejoinder
14 Jun, 2024
Oral Procedure
Jun 26, 2024
Decision

Case Details

    Case Number:

    UPC_CFI_124/2024

    Patent Number:

    EP3167888

    Filing Date:

    19 Mar, 2024

    Proceeding Type:

    Provisionalmeasures

    Case Phase:

    Case Closed

    Plaintiffs:

    • Alexion Pharmaceuticals

    Plaintiff Representative:

    • Elena Hennecke

    Defendants:

    • Amgen Technology Ireland Unlimited

    Defendant Representative:

    • Tilman Mueller-Stoy

    Judges:

    • Alima Zana
    • Rudi Goedeweeck
    • Sabine Klepsch
    • Stefan Schilling

    Court Division:

    First Instance, Local Division - Hamburg

Case Decision

    Decision Date:

    Jun 26, 2024

    Decision Document:

    View document

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

Last updated on: Oct 30, 2025
DateTitle

Notify me when new UPC document is filed

Sep 18, 2025Comments
Sep 10, 2025Receipt
Sep 10, 2025Outcome Of The Order
Sep 10, 2025Deadline Extension
Sep 9, 2025Deadline Extension Request
Sep 9, 2025262.2 Application
Sep 4, 2025Anonymisierte Version
Aug 26, 2025Template Order
Aug 26, 2025Anhoerung
Aug 25, 2025Outcome Of The Order
Aug 25, 2025Order With Grounds
Aug 20, 2025Receipt
Aug 20, 202520250820 Application For Rectification Amgen En Signiert
Aug 19, 2025Second Instance Application For Cost Decision Amgen Signed Confidential
Aug 19, 2025Request 9 1 Rop Costs Rehearing Amgen 33361 2025 35088 2025 Signed
Aug 19, 2025Request 9 1 Rop Costs First Instance Amgen 43687 2025 35086 2025 Signed
Aug 19, 2025Request 9 1 Rop Costs Appeal Proceedings Amgen 3053 2025 35087 2025 Signed
Aug 19, 2025Rehearing Application For Cost Decision Amgen Signed Confidential
Aug 19, 2025First Instance Reply Of Amgen 43687 2024 Signed Confidential
Aug 19, 2025First Instance Application For Cost Decision Amgen Signed Confidential
Aug 19, 2025Comments On Application For Rehearing Costs
Aug 19, 2025Application 262 2 Rop Costs Rehearing Amgen 33361 2025 Signed
Aug 19, 2025Application 262 2 Rop Costs First Instance Amgen 43687 2024 Signed
Aug 19, 2025Application 262 2 Rop Costs Appeal Proceedings Amgen 3053 2025 Signed
Aug 5, 2025Outcome Of The Order
Aug 5, 2025Order With Grounds
Aug 5, 2025Anhoerung
Aug 5, 2025262A
Aug 4, 2025Comments
Jul 28, 2025Anhoerung
Jul 22, 2025Receipt
Jul 21, 2025Confidentiality Request Re Application Cost Decision Rehearing En
Jul 21, 2025Application Cost Decision Rehearing Confidential En
Sep 30, 2024Outcome Of The Order
Sep 30, 2024Confirmation Of Appointment Oral Hearing Recording
Sep 26, 2024Receipt
Sep 25, 2024Request To The Registrar For The Recording Of The Oral Hearing To Be Made Available
Jul 17, 2024Order With Grounds (Ord 38132 2024)
Jun 26, 2024Recording
Jun 26, 2024Procedural Order
Jun 26, 2024Measures Decisionoutcome Notification
Jun 25, 2024Summons
Jun 25, 2024Closing Written Proceedings
Jun 18, 2024Closing Workflow
Jun 14, 2024Vorlage Skerra
Jun 14, 2024Rejoinder Of Amgen Confidential En Signed
Jun 14, 2024Exhibit Fbd 38A
Jun 14, 2024Exhibit Bp29 Confidential
Jun 14, 2024Exhibit Bp28
Jun 14, 2024Exhibit Bp27
Jun 14, 2024Exhibit Bp26
Jun 14, 2024Exhibit Bp25
Jun 14, 2024Exhibit Bp24
Jun 14, 2024Exhibit Bp23
Jun 14, 2024Exhibit Bp22
Jun 14, 2024Exhibit Bp21
Jun 14, 2024Exhibit Bp20
Jun 14, 2024Exhibit Bp19
Jun 14, 2024Exhibit Bp18
Jun 14, 2024Exhibit Bp17
Jun 14, 2024Comments
May 28, 2024Receipt
May 28, 2024Outcome Of The Order
May 28, 2024Deadline Amgen
May 27, 2024Application/Submission
May 24, 2024Receipt
May 24, 2024R 262 Application
May 24, 2024Part I Of The Reply
May 24, 2024Part Ii Of The Reply
May 24, 2024Outcome Of The Order
May 24, 2024Exhibit Fbd A 2
May 24, 2024Exhibit Fbd A 1
May 24, 2024Exhibit Fbd 67
May 24, 2024Exhibit Fbd 66
May 24, 2024Exhibit Fbd 65
May 24, 2024Exhibit Fbd 64
May 24, 2024Exhibit Fbd 63
May 24, 2024Exhibit Fbd 62
May 24, 2024Exhibit Fbd 61
May 24, 2024Exhibit Fbd 60
May 24, 2024Exhibit Fbd 59
May 24, 2024Exhibit Fbd 58
May 24, 2024Exhibit Fbd 57
May 24, 2024Exhibit Fbd 56
May 24, 2024Exhibit Fbd 55
May 24, 2024Exhibit Fbd 54
May 24, 2024Exhibit Fbd 53
May 24, 2024Exhibit Fbd 52
May 24, 2024Exhibit Fbd 51
May 24, 2024Exhibit Fbd 50
May 24, 2024Exhibit Fbd 49
May 24, 2024Exhibit Fbd 48
May 24, 2024Exhibit Fbd 47
May 24, 2024Exhibit Fbd 46
May 24, 2024Exhibit Fbd 45
May 24, 2024Exhibit Fbd 44
May 24, 2024Exhibit Fbd 43
May 24, 2024Exhibit Fbd 42
May 24, 2024Exhibit Fbd 41
May 24, 2024Exhibit Fbd 40
May 24, 2024Exhibit Fbd 39
May 24, 2024Exhibit Fbd 38
May 24, 2024Exhibit Fbd 37
May 24, 2024Exhibit Fbd 36
May 24, 2024Exhibit Fbd 35
May 24, 2024Duplik Defendant
May 24, 2024Closing Workflow
May 16, 2024Rule 9.3 Extension Request
May 16, 2024Receipt
May 16, 2024Outcome Of The Order
May 16, 2024Frist
May 16, 2024Anlage Fbd Fv 2
May 16, 2024Anlage Fbd Fv 1
May 7, 2024Outcome Of The Order
May 7, 2024Frist Applicant
May 3, 2024Summon To Oral Hearing
May 2, 2024Receipt
Apr 30, 2024Objection Amgen Dd April 30 2024 Confidential En Signed
Apr 30, 2024Exhibit Bp16 Amgen En
Apr 30, 2024Exhibit Bp15 Amgen En
Apr 30, 2024Exhibit Bp14 Amgen En
Apr 30, 2024Exhibit Bp13 Amgen En
Apr 30, 2024Exhibit Bp12 Amgen En
Apr 30, 2024Exhibit Bp11 Amgen File Wrapper Estoppel En
Apr 30, 2024Exhibit Bp10E Amgen Confidential Nl
Apr 30, 2024Exhibit Bp10D Amgen Confidential En
Apr 30, 2024Exhibit Bp10C Amgen Confidential En
Apr 30, 2024Exhibit Bp10B Amgen Confidential En
Apr 30, 2024Exhibit Bp10 Amgen Related Proceedings Confidential En
Apr 30, 2024Exhibit Bp10A Amgen Confidential De
Apr 30, 2024Exhibit Bp09P Amgen En
Apr 30, 2024Exhibit Bp09O Amgen En
Apr 30, 2024Exhibit Bp09N Amgen En
Apr 30, 2024Exhibit Bp09M Amgen En
Apr 30, 2024Exhibit Bp09L Amgen En
Apr 30, 2024Exhibit Bp09K Amgen En
Apr 30, 2024Exhibit Bp09J Amgen En
Apr 30, 2024Exhibit Bp09I Amgen En
Apr 30, 2024Exhibit Bp09H Amgen En
Apr 30, 2024Exhibit Bp09G Amgen En
Apr 30, 2024Exhibit Bp09F Amgen En
Apr 30, 2024Exhibit Bp09E Amgen En
Apr 30, 2024Exhibit Bp09D Amgen En
Apr 30, 2024Exhibit Bp09C Amgen En
Apr 30, 2024Exhibit Bp09B Amgen En
Apr 30, 2024Exhibit Bp09 Amgen Grant History En
Apr 30, 2024Exhibit Bp09A Amgen En
Apr 30, 2024Exhibit Bp08 Amgen Table Grant Procedures En
Apr 30, 2024Exhibit Bp07 Amgen En
Apr 30, 2024Exhibit Bp06 Amgen En
Apr 30, 2024Exhibit Bp05 Amgen En
Apr 30, 2024Exhibit Bp04 Amgen Confidential En
Apr 30, 2024Exhibit Bp03 Amgen Technical Background En
Apr 30, 2024Exhibit Bp02 Amgen En
Apr 30, 2024Exhibit Bp01 Amgen En
Apr 30, 2024Exhibit Bp00 Amgen En Signed
Apr 17, 2024Panel Appointment
Apr 14, 2024Template Order
Apr 14, 2024Procedural Order
Apr 9, 2024Receipt
Apr 9, 2024Notification Of Service
Apr 9, 2024Mail Service Sweden
Apr 9, 2024Antrag/Schriftsatz
Apr 9, 2024Acknowledgement Of Access To Case
Apr 2, 2024Acknowledgement Of Access To Case
Mar 28, 2024Service Italy
Mar 28, 2024Service Italien
Mar 28, 2024Service French
Mar 28, 2024Service Frankreich
Mar 28, 2024Notification Of Service
Mar 27, 2024Service Portugal
Mar 27, 2024Service Munich
Mar 27, 2024Service Belgium
Mar 27, 2024Notification Of Service
Mar 26, 2024Service Slovenia
Mar 26, 2024Service Ireland
Mar 26, 2024Service Austria
Mar 26, 2024Panel Appointment
Mar 26, 2024Notification Of Service
Mar 20, 2024Receipt
Mar 20, 2024Letter For Service
Mar 20, 2024Invitation To Lodge
Mar 19, 2024Set Of Exhibits Fbd 5B
Mar 19, 2024Set Of Exhibits Fbd 5A
Mar 19, 2024Panel Appointment
Mar 19, 2024Formal Checks Notification Of Positive Outcome
Mar 19, 2024Exhibit Fbd 9
Mar 19, 2024Exhibit Fbd 8
Mar 19, 2024Exhibit Fbd 7
Mar 19, 2024Exhibit Fbd 6
Mar 19, 2024Exhibit Fbd 4
Mar 19, 2024Exhibit Fbd 34
Mar 19, 2024Exhibit Fbd 33A
Mar 19, 2024Exhibit Fbd 33
Mar 19, 2024Exhibit Fbd 32A
Mar 19, 2024Exhibit Fbd 32
Mar 19, 2024Exhibit Fbd 31
Mar 19, 2024Exhibit Fbd 30
Mar 19, 2024Exhibit Fbd 3
Mar 19, 2024Exhibit Fbd 29
Mar 19, 2024Exhibit Fbd 28
Mar 19, 2024Exhibit Fbd 27
Mar 19, 2024Exhibit Fbd 26
Mar 19, 2024Exhibit Fbd 25
Mar 19, 2024Exhibit Fbd 24
Mar 19, 2024Exhibit Fbd 23
Mar 19, 2024Exhibit Fbd 22
Mar 19, 2024Exhibit Fbd 21
Mar 19, 2024Exhibit Fbd 20
Mar 19, 2024Exhibit Fbd 19
Mar 19, 2024Exhibit Fbd 18A
Mar 19, 2024Exhibit Fbd 18
Mar 19, 2024Exhibit Fbd 17C
Mar 19, 2024Exhibit Fbd 17B
Mar 19, 2024Exhibit Fbd 17A
Mar 19, 2024Exhibit Fbd 16
Mar 19, 2024Exhibit Fbd 15
Mar 19, 2024Exhibit Fbd 14
Mar 19, 2024Exhibit Fbd 13
Mar 19, 2024Exhibit Fbd 12
Mar 19, 2024Exhibit Fbd 11
Mar 19, 2024Exhibit Fbd 10
Mar 19, 2024Exhibit Fbd 1
Mar 19, 2024Exhibit Fbd 0
Mar 19, 2024Confidential Exhibit Fbd 2
Mar 19, 2024Application To Request Confidentiality From The Public
Mar 19, 2024Application For Provisional Measures
Mar 19, 2024Application For Measures Receipt
Mar 19, 2024Application For Measures Acknowledgement

More cases involving EP3167888B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
UPC_CFI_674/2025Jul 22, 2025Samsung Bioepis NLAlexion Pharmaceuticals
UPC_CFI_51/2025Jan 23, 2025Samsung Bioepis NLAlexion Pharmaceuticals
UPC_CFI_40/2025Jan 22, 2025Samsung Bioepis NLAlexion Pharmaceuticals

More cases involving Alexion Pharmaceuticals

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_35353/2025Aug 22, 2025Alexion Pharmaceuticals -
APP_35118/2025Aug 20, 2025Alexion Pharmaceuticals -
APP_35143/2025Aug 20, 2025Alexion Pharmaceuticals -

More cases involving Amgen Technology Ireland Unlimited

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_35200/2025Aug 21, 2025Amgen Technology Ireland Unlimited -
APP_35086/2025Aug 20, 2025Amgen Technology Ireland Unlimited -
APP_35087/2025Aug 20, 2025Amgen Technology Ireland Unlimited -